Start Date: ,
End Date: ,
Click here to access the article.
We analyzed prospectively collected clinical data from all consecutive patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who were referred for ECMO to a single center between January 1, 2021, and August 31, 2021. For all referrals, a standardized case report form was used to record patient characteristics (as listed in Table 1) and the result of a multidisciplinary committee’s determination of whether the patient was eligible for ECMO.